Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
No holdings reported for quarter Q4 2014 |
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
FREEPORT-MCMORAN INC | 19 | Q2 2024 | 27.7% |
ALPHABET INC | 17 | Q2 2024 | 20.3% |
PARSONS CORPORATION | 15 | Q2 2024 | 6.5% |
TJX COS INC NEW | 14 | Q2 2024 | 9.6% |
GENERAL MTRS CO | 14 | Q2 2024 | 10.8% |
FISERV INC | 12 | Q2 2024 | 8.6% |
PAYPAL HLDGS INC | 11 | Q2 2022 | 12.0% |
JPMORGAN CHASE & CO | 10 | Q2 2024 | 8.5% |
SAGE THERAPEUTICS INC | 9 | Q4 2021 | 12.2% |
DECIPHERA PHARMACEUTICALS IN | 8 | Q3 2021 | 15.3% |
View Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s complete holdings history.
Latest filings
Type | Filed |
---|---|
N-PX | 2024-08-27 |
13F-HR | 2024-07-19 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
13F-HR | 2024-05-17 |
View Nationale-Nederlanden Powszechne Towarzystwo Emerytalne S.A.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.